{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:43:31Z","timestamp":1790052211648,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81801997"],"award-info":[{"award-number":["81801997"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.clinbiochem.2025.110981","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T23:00:17Z","timestamp":1753225217000},"page":"110981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["LRG and NGAL are potential diagnosis and disease activity biomarkers for inflammatory bowel disease"],"prefix":"10.1016","volume":"139","author":[{"given":"Dongdan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaomei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clinbiochem.2025.110981_b0005","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/jebm.12626","article-title":"Diagnosis and management of inflammatory bowel disease","volume":"17","author":"Li","year":"2024","journal-title":"J. Evid. Based Med."},{"issue":"Suppl 2","key":"10.1016\/j.clinbiochem.2025.110981_b0010","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/ibd\/izae092","article-title":"Overview to challenges in IBD 2024-2029","volume":"30","author":"Heller","year":"2024","journal-title":"Inflamm. Bowel Dis."},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110981_b0015","first-page":"5","article-title":"Historical perspectives: malignancy in Crohn's disease and ulcerative colitis","volume":"37","author":"Williams","year":"2023","journal-title":"Clin. Colon Rectal Surg."},{"key":"10.1016\/j.clinbiochem.2025.110981_b0020","article-title":"Characterizing the pre-clinical phase of inflammatory bowel disease","volume":"4","author":"Vestergaard","year":"2023","journal-title":"Cell Rep. Med."},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110981_b0025","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12874-023-01944-2","article-title":"Ng SC; GIVES-21 Consortium. Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21st century (GIVES-21)","volume":"23","author":"Mak","year":"2023","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.clinbiochem.2025.110981_b0030","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.bpg.2016.09.005","article-title":"Complications of diagnostic colonoscopy, upper endoscopy, and enteroscopy","volume":"30","author":"Levy","year":"2016","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"issue":"10","key":"10.1016\/j.clinbiochem.2025.110981_b0035","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.3390\/jcm13102957","article-title":"Serum leucine-rich \u03b12 glycoprotein could be a useful biomarker to differentiate patients with normal colonic mucosa from those with inflammatory bowel disease or other forms of colitis","volume":"13","author":"Horiuchi","year":"2024","journal-title":"J. Clin. Med."},{"issue":"6","key":"10.1016\/j.clinbiochem.2025.110981_b0040","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3892\/mmr.2022.12875","article-title":"Lipocalin 2 activates the NLRP3 inflammasome via LPS\u2011induced NF\u2011\u03baB signaling and plays a role as a pro\u2011inflammatory regulator in murine macrophages","volume":"26","author":"Kim","year":"2022","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.clinbiochem.2025.110981_b0045","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/cei.12136","article-title":"Expression of Toll-like receptor-3 is enhanced in active inflammatory bowel disease and mediates the excessive release of lipocalin 2","volume":"173","author":"\u00d8stvik","year":"2013","journal-title":"Clin. Exp. Immunol."},{"issue":"4","key":"10.1016\/j.clinbiochem.2025.110981_b0050","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jcmgh.2016.03.007","article-title":"Microbiota-inducible innate immune, siderophore binding protein lipocalin 2 is critical for intestinal homeostasis","volume":"2","author":"Singh","year":"2016","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.clinbiochem.2025.110981_b0055","first-page":"2403","article-title":"Evaluation of serum neutrophil gelatinase-associated lipocalin (NGAL), asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) levels, and their relations with disease type and activity in inflammatory bowel diseases","volume":"51","author":"Korkmaz","year":"2021","journal-title":"Turk. J. Med. Sci."},{"issue":"9","key":"10.1016\/j.clinbiochem.2025.110981_b0060","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1007\/s10620-013-2676-z","article-title":"Relationship between neutrophil gelatinase-associated lipocalin (NGAL) levels and inflammatory bowel disease type and activity","volume":"58","author":"Ye\u015fil","year":"2013","journal-title":"Dig. Dis. Sci."},{"issue":"2","key":"10.1016\/j.clinbiochem.2025.110981_b0065","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00441-018-2860-8","article-title":"Expression of neutrophil gelatinase-associated lipocalin (NGAL) in the gut in Crohn's disease","volume":"374","author":"Thorsvik","year":"2018","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.clinbiochem.2025.110981_b0070","article-title":"GEDII. serum neutrophil biomarkers to predict Crohn's disease progression and infliximab treatment outcomes","author":"Magalhaes","year":"2024","journal-title":"United Eur. Gastroenterol. J."},{"issue":"9","key":"10.1016\/j.clinbiochem.2025.110981_b0075","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1111\/jgh.15907","article-title":"Serum leucine-rich alpha-2 glycoprotein as a predictive factor of endoscopic remission in Crohn's disease","volume":"37","author":"Abe","year":"2022","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"11","key":"10.1016\/j.clinbiochem.2025.110981_b0080","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1002\/ibd.22936","article-title":"Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis","volume":"18","author":"Serada","year":"2012","journal-title":"Inflamm. Bowel Dis."},{"issue":"2","key":"10.1016\/j.clinbiochem.2025.110981_b0085","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/13497413.2018.1481582","article-title":"LRG is a novel inflammatory marker clinically useful for the evaluation of disease activity in rheumatoid arthritis and inflammatory bowel disease","volume":"41","author":"Naka","year":"2018","journal-title":"Immunol. Med."},{"issue":"8","key":"10.1016\/j.clinbiochem.2025.110981_b0090","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1002\/art.39164","article-title":"Leucine-rich \u03b12 -glycoprotein as a potential biomarker for joint inflammation during anti-interleukin-6 biologic therapy in rheumatoid arthritis","volume":"67","author":"Fujimoto","year":"2015","journal-title":"Arthritis Rheumatol."},{"issue":"6","key":"10.1016\/j.clinbiochem.2025.110981_b0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0286415","article-title":"Application of plasma alternative to serum for measuring leucine-rich \u03b12-glycoprotein as a biomarker of inflammatory bowel disease","volume":"18","author":"Ichimiya","year":"2023","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.clinbiochem.2025.110981_b0100","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s00535-021-01793-0","article-title":"Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study","volume":"56","author":"Shinzaki","year":"2021","journal-title":"J. Gastroenterol."},{"issue":"2021","key":"10.1016\/j.clinbiochem.2025.110981_b0105","article-title":"Evaluation of serum leucine-rich alpha-2 glycoprotein as a new inflammatory biomarker of inflammatory bowel disease","volume":"1","author":"Yoshimura","year":"2021","journal-title":"Mediators Inflamm."},{"issue":"7","key":"10.1016\/j.clinbiochem.2025.110981_b0110","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/jgh.16166","article-title":"Serum leucine-rich alpha-2 glycoprotein and calprotectin in children with inflammatory bowel disease: a multicenter study in Japan","volume":"38","author":"Yasuda","year":"2023","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.clinbiochem.2025.110981_b0115","unstructured":"Chinese Society of Gastroenterology IBD Group, Chinese IBD Quality Control and Evaluation Center, Wu KC, Chen MH, Qian JM. Chinese Guidelines for Diagnosis and Treatment of Ulcerative Colitis (2023, Xi'an) [J]. J Gastroenterol. 2024;29(3):145-173. doi:10.3969\/j.issn.1008-7125.2024.03.003 (in Chinese)."},{"key":"10.1016\/j.clinbiochem.2025.110981_b0120","unstructured":"Chinese Society of Gastroenterology IBD Group, Chinese IBD Quality Control and Evaluation Center, Chen MH, Wu KC. Chinese Guidelines for Diagnosis and Treatment of Crohn's Disease (2023, Guangzhou) [J]. J Gastroenterol. 2024;29(4):200-235. doi:10.3969\/j.issn.1008-7125.2024.04.002 (in Chinese)."},{"issue":"3","key":"10.1016\/j.clinbiochem.2025.110981_b0125","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1080\/13813455.2020.1720742","article-title":"Association between neutrophil gelatinase-associated lipocalin (NGAL) and iron profile in chronic renal disease","volume":"128","author":"Aghsaeifard","year":"2022","journal-title":"Arch. Physiol. Biochem."},{"issue":"19","key":"10.1016\/j.clinbiochem.2025.110981_b0130","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.3390\/jcm11195618","article-title":"Circulating profile of ECM-related proteins as diagnostic markers in inflammatory bowel diseases","volume":"11","author":"Komosinska-Vassev","year":"2022","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.clinbiochem.2025.110981_b0135","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1053\/j.gastro.2006.03.054","article-title":"Angiogenesis as a novel component of inflammatory bowel disease pathogenesis","volume":"130","author":"Danese","year":"2006","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.clinbiochem.2025.110981_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0282153","article-title":"Serum leucine-rich \u03b12 glycoprotein as a potential biomarker for systemic inflammation in Parkinson's disease","volume":"18","author":"Ohmichi","year":"2023","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.clinbiochem.2025.110981_b0145","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/gutjnl-2012-302717","article-title":"Serological markers predict inflammatory bowel disease years before the diagnosis","volume":"62","author":"van Schaik","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.clinbiochem.2025.110981_b0150","unstructured":"Iijima H, Shinzaki S, Tsujii M, Takehara T. [Biomarkers in the diagnosis and therapy of inflammatory bowel diseases]. Nihon Rinsho. 2012 May;70(5):869-73. Japanese. PMID: 22620015."},{"issue":"7","key":"10.1016\/j.clinbiochem.2025.110981_b0155","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1164\/rccm.200908-1214OC","article-title":"Neutrophil gelatinase-associated lipocalin at ICU admission predicts for acute kidney injury in adult patients","volume":"183","author":"Geus","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.clinbiochem.2025.110981_b0160","first-page":"E122","article-title":"Significance of serum leucine-rich alpha-2 glycoprotein as a diagnostic marker in pediatric inflammatory bowel disease","volume":"69","author":"Yoshimura","year":"2024","journal-title":"Kobe J. Med. Sci."},{"issue":"5","key":"10.1016\/j.clinbiochem.2025.110981_b0165","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00535-011-0516-5","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) in inflammatory bowel disease: association with pathophysiology of inflammation, established markers, and disease activity","volume":"47","author":"Oikonomou","year":"2012","journal-title":"J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.clinbiochem.2025.110981_b0170","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1111\/j.1572-0241.1999.01439.x","article-title":"Rectal dialysate and fecal concentrations of neutrophil gelatinase-associated lipocalin, interleukin-8, and tumor necrosis factor-alpha in ulcerative colitis","volume":"94","author":"Nielsen","year":"1999","journal-title":"Am. J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.clinbiochem.2025.110981_b0175","first-page":"1","article-title":"New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD","volume":"16","author":"Larabi","year":"2019","journal-title":"Autophagy"},{"issue":"5","key":"10.1016\/j.clinbiochem.2025.110981_b0180","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.clinbiochem.2025.110981_b0185","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1620\/tjem.2022.J042","article-title":"Leucine-rich alpha-2 glycoprotein in monitoring disease activity and intestinal stenosis in inflammatory bowel disease","volume":"257","author":"Yoshida","year":"2022","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.clinbiochem.2025.110981_b0190","article-title":"The utility of fecal calprotectin in the real-world clinical care of patients with inflammatory bowel disease","volume":"2016","author":"Abej","year":"2016","journal-title":"Can. J. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.clinbiochem.2025.110981_b0195","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/ueg2.12069","article-title":"International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases","volume":"9","author":"D'Amico","year":"2021","journal-title":"United Eur. Gastroenterol. J."},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.110981_b0200","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000530825","article-title":"Optimal use of serum leucine- rich alpha- 2 glycoprotein as a biomarker for small bowel lesions of Crohn's disease","volume":"8","author":"Asonuma","year":"2023","journal-title":"Inflam. Intest. Dis."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912025001109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912025001109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T13:31:46Z","timestamp":1766842306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912025001109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":40,"alternative-id":["S0009912025001109"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2025.110981","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LRG and NGAL are potential diagnosis and disease activity biomarkers for inflammatory bowel disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2025.110981","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110981"}}